AbbVie
ABBV
#31
Rank
S$414.42 B
Marketcap
$234.52
Share price
-1.29%
Change (1 day)
9.04%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Market capitalization of AbbVie (ABBV)

Market cap: S$414.42 Billion

As of January 2025 AbbVie has a market cap of S$414.42 Billion. This makes AbbVie the world's 31th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AbbVie from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025S$414.42 B-3.08%
2024S$427.58 B18.33%
2023S$361.35 B-5.69%
2022S$383.14 B18.4%
2021S$323.60 B29.31%
2020S$250.26 B41.76%
2019S$176.53 B-5.22%
2018S$186.25 B-9.8%
2017S$206.49 B40.21%
2016S$147.28 B9.18%
2015S$134.90 B-1.96%
2014S$137.60 B29.56%
2013S$106.20 B60.91%
2012S$66.00 B

End of Day market cap according to different sources

On Jan 14th, 2025 the market cap of AbbVie was reported to be:

S$423.79 Billion
by Yahoo Finance info icon info icon
S$423.79 Billion
by CompaniesMarketCap info icon info icon
S$423.67 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
S$204.53 B-50.65%๐Ÿ‡บ๐Ÿ‡ธ USA
S$156.69 B-62.19%๐Ÿ‡บ๐Ÿ‡ธ USA
S$919.38 B 121.84%๐Ÿ‡บ๐Ÿ‡ธ USA
S$199.09 B-51.96%๐Ÿ‡บ๐Ÿ‡ธ USA
S$156.56 B-62.22%๐Ÿ‡บ๐Ÿ‡ธ USA
S$28.76 B-93.06%๐Ÿ‡บ๐Ÿ‡ธ USA
S$92.18 B-77.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$279.53 B-32.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$19.55 B-95.28%๐Ÿ‡บ๐Ÿ‡ธ USA